Airtech Seeks Approval for Insurance Reimbursement.

Business Editors

DALLAS--(BUSINESS WIRE)--Feb. 12, 2001

Airtech International Group, Inc. (OTCBB:AIRG) announced today the Company has signed a contract and provided research documentation to H.H. Enterprises Inc., (HHE) of Knoxville, Tenn. to obtain approval for Insurance Reimbursement for its air sterilization technology.

HHE is a nationally recognized health care consulting firm with a successful fifteen-year track record of assisting in the procurement of insurance reimbursement for medical devices. HHE has successfully completed projects for a number of high profile clients such as; Johnson & Johnson, Medline, Baxter Labs, and Symphony Health Care.

HHE, President Rick Hensley, stated, "Once insurance reimbursement is established for the cutting edge Airtech product, coverage should be available through most of the nation's insurance carriers. The establishment of insurance reimbursement can allow this technology to be reimbursed for the millions of patients suffering from conditions of chronic upper respiratory distress, as opposed to being an out-of-pocket expense to the patient. Reimbursement for this technology will give payers of medical care, the opportunity to substantially reduce the overall treatment costs for caring for these types of patients, while drastically increasing the patient's quality of life. We look forward to working with Airtech in the successful completion of this project, and the important contribution that this air sterilization technology will make to patient care." Final documentation must be submitted by March 31, 2001 in order to receive coverage and reimbursement this year.

Airtech President John Harris commented, "This is a significant opportunity for the Company and its shareholders. The attainment of insurance reimbursement could open up the market for any patient covered by a health insurance program to be eligible for our product and subsequently receive reimbursement for it. Our portable air sterilization system (Airsopure Model S-950) will be the lead product, and could produce millions of dollars of revenue to the Company.

Harris added, "Millions of Americans suffer from debilitating conditions such as asthma, severe allergies, pneumonia, COPD and emphysema. These individuals suffer from their diagnosed disease, but research shows that they are highly susceptible to opportunistic bacteria and viruses, in addition to harmful gases such as formaldehyde and carbon monoxide that will complicate their preexisting conditions. Airtech's technology can be a major adjunct to the treatment regimen of these patients, and the availability of insurance reimbursement for our products should decrease patient suffering and the overall cost of treatment."

The Company first achieved market recognition with its air purification technology by providing a simple solution using advanced technology and engineering to allows smokers and non-smokers to co-exist in restaurant/ bars. Its corporate customers include: Southwest Airlines, Alphagraphic's, El Chico's, Bennigan's, TGI Friday's, Del Frisco's Double Eagle Steakhouses, Sullivan's, and many other companies. Airtech International Group Inc., (www.airtechgroup.com), is a publicly traded company under the symbol (OTCBB:AIRG). Airsopure, Inc., (www.airsopure.com) is a wholly owned subsidiary of Airtech.

Forward looking Statements in this document that are not historical fact are "forward-looking statements" as that term is defined in the Private Securities Litigation Reform of 1995. Forward-looking statements are not guarantees of future performance. Our forward-looking statements are based on trends that we anticipate in our industry and our good faith estimate of the effect on these trends of such factors as industry capacity, product demand and product pricing. These statements are also subject to risks and uncertainties beyond our reasonable control that could cause our actual business and results of operations to differ materially from those reflected in our forward-looking statements. These risks are described in the Company's Form10-K filed September 7, 2000.